Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan J, Mbanya JC et al (2022) IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119. https://doi.org/10.1016/j.diabres.2021.109119
Schleicher E, Gerdes C, Petersmann A, Muller-Wieland D, Muller UA, Freckmann G, Heinemann L, Nauck M, Landgraf R (2022) Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes 130(01):S1–S8. https://doi.org/10.1055/a-1624-2897
Article CAS PubMed Google Scholar
Pearson ER (2019) Type 2 diabetes: a multifaceted disease. Diabetologia 62(7):1107–1112. https://doi.org/10.1007/s00125-019-4909-y
Article PubMed PubMed Central Google Scholar
McCarthy MI (2017) Painting a new picture of personalised medicine for diabetes. Diabetologia 60(5):793–799. https://doi.org/10.1007/s00125-017-4210-x
Article PubMed PubMed Central Google Scholar
Ahlqvist E, Storm P, Karajamaki A, Martinell M, Dorkhan M, Carlsson A, Vikman P, Prasad RB, Aly DM, Almgren P et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6(5):361–369. https://doi.org/10.1016/S2213-8587(18)30051-2
Ahlqvist E, Prasad RB, Groop L (2020) Subtypes of type 2 diabetes determined from clinical parameters. Diabetes 69(10):2086–2093. https://doi.org/10.2337/dbi20-0001
Article CAS PubMed Google Scholar
Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT (2019) Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol 7(6):442–451. https://doi.org/10.1016/S2213-8587(19)30087-7
Article PubMed PubMed Central Google Scholar
Zaharia OP, Strassburger K, Strom A, Bonhof GJ, Karusheva Y, Antoniou S, Bodis K, Markgraf DF, Burkart V, Mussig K et al (2019) Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 7(9):684–694. https://doi.org/10.1016/S2213-8587(19)30187-1
Tanabe H, Saito H, Kudo A, Machii N, Hirai H, Maimaituxun G, Tanaka K, Masuzaki H, Watanabe T, Asahi K et al (2020) Factors associated with risk of diabetic complications in novel cluster-based diabetes subgroups: a Japanese retrospective cohort study. J Clin Med 9(7):2083. https://doi.org/10.3390/jcm9072083
Article PubMed PubMed Central Google Scholar
Zou X, Zhou X, Zhu Z, Ji L (2019) Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol 7(1):9–11. https://doi.org/10.1016/S2213-8587(18)30316-4
Maalmi H, Herder C, Bonhof GJ, Strassburger K, Zaharia OP, Rathmann W, Burkart V, Szendroedi J, Roden M, Ziegler D (2022) Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes. Diabetologia 65(3):552–562. https://doi.org/10.1007/s00125-021-05607-z
Article CAS PubMed Google Scholar
Hwang YC, Ahn HY, Jun JE, Jeong IK, Ahn KJ, Chung HY (2023) Subtypes of type 2 diabetes and their association with outcomes in Korean adults - a cluster analysis of community-based prospective cohort. Metabolism 141:155514. https://doi.org/10.1016/j.metabol.2023.155514
Article CAS PubMed Google Scholar
Christensen DH, Nicolaisen SK, Ahlqvist E, Stidsen JV, Nielsen JS, Hojlund K, Olsen MH, Garcia-Calzon S, Ling C, Rungby J et al (2022) Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 diabetes (DD2) cohort. Bmj Open Diabetes Res Care 10(2):e002731. https://doi.org/10.1136/bmjdrc-2021-002731
Article PubMed PubMed Central Google Scholar
Hwang YC, Jeon WS, Park CY, Youn BS (2016) The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype. Cardiovasc Diabetol 15:9. https://doi.org/10.1186/s12933-015-0319-8
Article CAS PubMed PubMed Central Google Scholar
Li X, Yang S, Cao C, Yan X, Zheng L, Zheng L, Da J, Tang X, Ji L, Yang X et al (2020) Validation of the Swedish diabetes re-grouping scheme in adult-onset diabetes in China. J Clin Endocrinol Metab 105(10):dgaa524. https://doi.org/10.1210/clinem/dgaa524
Lyu J, Li Z, Wei H, Liu D, Chi X, Gong DW, Zhao Q (2020) A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China. Acta Diabetol 57(6):705–713. https://doi.org/10.1007/s00592-020-01484-x
Article CAS PubMed PubMed Central Google Scholar
Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7%3C539::AID-DIA668%3E3.0.CO;2-S
Article CAS PubMed Google Scholar
Mirr M, Skrypnik D, Bogdanski P, Owecki M (2021) Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest 44(12):2831–2843. https://doi.org/10.1007/s40618-021-01608-2
Article CAS PubMed PubMed Central Google Scholar
Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT (2010) Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 5(6):1003–1009. https://doi.org/10.2215/CJN.06870909
Article PubMed PubMed Central Google Scholar
Stevens PE, Levin A (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825–830. https://doi.org/10.7326/0003-4819-158-11-201306040-00007
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, Maia M, Mathenge W, Moreker S, Muqit M et al (2018) Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology 125(10):1608–1622. https://doi.org/10.1016/j.ophtha.2018.04.007
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D (2017) Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 40(1):136–154. https://doi.org/10.2337/dc16-2042
Article CAS PubMed Google Scholar
American Diabetes Association (2003) Peripheral arterial disease in people with diabetes. Diabetes Care 26(12):3333–3341. https://doi.org/10.2337/diacare.26.12.3333
Opoku S, Gan Y, Yobo EA, Tenkorang-Twum D, Yue W, Wang Z, Lu Z (2021) Awareness, treatment, control, and determinants of dyslipidemia among adults in China. Sci Rep 11(1):10056. https://doi.org/10.1038/s41598-021-89401-2
Article CAS PubMed PubMed Central Google Scholar
Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L (2018) Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol 24(30):3361–3373. https://doi.org/10.3748/wjg.v24.i30.3361
Article PubMed PubMed Central Google Scholar
Flack JM, Adekola B (2020) Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med 30(3):160–164. https://doi.org/10.1016/j.tcm.2019.05.003
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R et al (2012) European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 223(1):1–68. https://doi.org/10.1016/j.atherosclerosis.2012.05.007
留言 (0)